Clinical Trial Update: Safety, Tolerability and Efficacy of Regorafenib in Combination With FOLFIRINOX in Patients With Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reports safety, tolerability, and preliminary efficacy of combining regorafenib with FOLFIRINOX in patients with metastatic colorectal can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• Stivarga (regorafenib)

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-01-15